From oral health to predictive medicine
OralAI is an advanced predictive platform that transforms oral health into a reliable indicator of systemic health. By integrating multi-source clinical data, 3D intraoral scans, radiographs, and CBCT imaging, the platform builds an advanced digital patient model that predicts health trajectories with clinical precision.
Developed according to EU MDR 2017/745 standards as a Diagnostic Support System (DSS), OralAI is a clinical decision support system that supports FDA certification pathways and represents a significant innovation for preventive medicine and predictive diagnostics. Intellectual property owned by Alessandra Marziali. Perfect for dental practices, corporate clinics, and healthcare insurance partners.
An interactive preview of the real platform. Scroll, explore and discover the user experience.
Advanced predictive medicine based on multimodal intelligence.
Collection and integration of data from clinical records, medical history, hematological tests, and vital parameters for holistic clinical vision.
Acquisition and processing of high-resolution 3D intraoral scans for detailed analysis of oral tissues and hard structures.
Integration of traditional radiographs and CBCT with AI algorithms for automated radiological diagnostics and precise 3D segmentation.
Construction of a digital twin of the patient that evolves over time, tracking changes in oral and systemic health in a continuous manner.
Advanced AI predictive models calculate the probability of future systemic pathologies based on oral indicators, supporting preventive medicine.
Development compliant with EU MDR 2017/745 (Diagnostic Support System) with defined roadmap for FDA certification and international authorizations.
OralAI is aimed at:
Intellectual Property: OralAI is proprietary technology developed by Alessandra Marziali, created according to rigorous medical standards and EU and international regulations.